SEC
|
Antal James
|
N/A
|
|
+16K
|
$10.26
|
+$163.98K
|
|
SEC
|
DURNAN JAYMIE A
|
N/A
|
|
+16K
|
$10.26
|
+$163.98K
|
|
SEC
|
Kane Julie
|
N/A
|
|
+16K
|
$10.26
|
+$163.98K
|
|
SEC
|
Marshall Joseph W III
|
N/A
|
|
+16K
|
$10.26
|
+$163.98K
|
|
SEC
|
Nabel Gary J.
|
N/A
|
|
+16K
|
$10.26
|
+$163.98K
|
|
SEC
|
Nemirovsky Julian
|
N/A
|
|
+16K
|
$10.26
|
+$163.98K
|
|
SEC
|
Phillips Holly L.
|
N/A
|
|
+16K
|
$10.26
|
+$163.98K
|
|
SEC
|
Plansky Michael C.
|
N/A
|
|
+16K
|
$10.26
|
+$163.98K
|
|
SEC
|
Antal James
|
N/A
|
|
-30K
|
$7.82
|
-$234.60K
|
|
SEC
|
Abrams Robin Elizabeth
|
General Counsel and CAO
|
|
+15K
|
$1.90
|
+$29.20K
|
|
SEC
|
Luckshire Daniel J
|
Executive VP & CFO
|
|
+13K
|
$2.18
|
+$27.83K
|
|
SEC
|
Antal James
|
N/A
|
|
-30K
|
$7.10
|
-$213.00K
|
|
SEC
|
Abrams Robin Elizabeth
|
General Counsel and CAO
|
|
+13K
|
$2.22
|
+$27.81K
|
|
SEC
|
Luckshire Daniel J
|
Executive VP & CFO
|
|
+14K
|
$2.10
|
+$28.69K
|
|
SEC
|
Gomez Phillip Louis III
|
Chief Executive Officer
|
|
+10K
|
$4.42
|
+$44.20K
|
|
SEC
|
Kane Julie
|
N/A
|
|
+2.5K
|
$4.39
|
+$10.98K
|
|
SEC
|
Luckshire Daniel J
|
Executive VP & CFO
|
|
+5K
|
$4.39
|
+$21.95K
|
|
SEC
|
SAVAS PAUL G
|
N/A
|
|
+20K
|
$4.37
|
+$87.40K
|
|
SEC
|
Gomez Phillip Louis III
|
Chief Executive Officer
|
|
+150K
|
$1.62
|
+$243.14K
|
|
SEC
|
ROSE ERIC A MD
|
N/A
|
|
+45K
|
$1.74
|
+$79.17K
|
|
SEC
|
SAVAS PAUL G
|
N/A
|
|
+10K
|
$4.95
|
+$49.50K
|
|
SEC
|
SAVAS PAUL G
|
N/A
|
|
+10K
|
$5.08
|
+$50.80K
|
|
SEC
|
Abrams Robin Elizabeth
|
General Counsel and CAO
|
|
+14K
|
$1.82
|
+$25.26K
|
|
SEC
|
Luckshire Daniel J
|
Executive VP & CFO
|
|
+14K
|
$1.82
|
+$25.26K
|
|
SEC
|
Hruby Dennis E
|
VP & Chief Scientific Officer
|
|
-50K
|
$5.61
|
-$280.50K
|
|
SEC
|
Antal James
|
N/A
|
|
-30K
|
$5.70
|
-$171.00K
|
|
SEC
|
BAYER MICHAEL J
|
N/A
|
|
-1.5K
|
$3.50
|
-$5.11K
|
|
SEC
|
Marshall Joseph W III
|
N/A
|
|
+9.8K
|
$5.89
|
+$57.54K
|
|
SEC
|
Luckshire Daniel J
|
Executive VP & CFO
|
|
+30K
|
$4.46
|
+$135.37K
|
|
SEC
|
Gomez Phillip Louis III
|
Chief Executive Officer
|
|
+301K
|
$1.82
|
+$547.26K
|
|
SEC
|
ROSE ERIC A MD
|
N/A
|
|
+94K
|
$1.92
|
+$180.68K
|
|
SEC
|
SAVAS PAUL G
|
N/A
|
|
+5K
|
$5.58
|
+$27.90K
|
|
SEC
|
Hruby Dennis E
|
VP & Chief Scientific Officer
|
|
-50K
|
$5.17
|
-$258.50K
|
|
SEC
|
Gomez Phillip Louis III
|
Chief Executive Officer
|
|
+15K
|
$5.20
|
+$78.00K
|
|
SEC
|
SAVAS PAUL G
|
N/A
|
|
+10K
|
$5.01
|
+$50.10K
|
|
SEC
|
BAYER MICHAEL J
|
N/A
|
|
+10K
|
$3.95
|
+$40.46K
|
|
SEC
|
Hruby Dennis E
|
VP & Chief Scientific Officer
|
|
+39K
|
$4.66
|
+$183.25K
|
|
SEC
|
Abrams Robin Elizabeth
|
General Counsel and CAO
|
|
+8K
|
$2.54
|
+$20.36K
|
|
SEC
|
ROSE ERIC A MD
|
Executive Chairman
|
|
+166K
|
$4.52
|
+$749.07K
|
|
SEC
|
Antal James
|
N/A
|
|
+4.4K
|
$4.52
|
+$19.83K
|
|
SEC
|
CONSTANCE THOMAS E
|
N/A
|
|
+4.3K
|
$4.50
|
+$19.38K
|
|
SEC
|
SAVAS PAUL G
|
N/A
|
|
+4.3K
|
$4.51
|
+$19.59K
|
|
SEC
|
ROSE ERIC A MD
|
Executive Chairman
|
|
+48K
|
$3.85
|
+$186.11K
|
|
SEC
|
Hruby Dennis E
|
VP & Chief Scientific Officer
|
|
+42K
|
$3.84
|
+$160.24K
|
|
SEC
|
Hruby Dennis E
|
VP & Chief Scientific Officer
|
|
+15K
|
$0.86
|
+$12.54K
|
|
SEC
|
Luckshire Daniel J
|
Executive VP & CFO
|
|
+19K
|
$0.87
|
+$16.80K
|
|
SEC
|
ROSE ERIC A MD
|
Executive Chairman
|
|
+37K
|
$0.90
|
+$33.45K
|
|
SEC
|
MacAndrews & Forbes LLC
|
N/A
|
|
+200K
|
$1.50
|
+$299.59K
|
|
SEC
|
SLOVIN BRUCE
|
N/A
|
|
-25K
|
$1.35
|
-$33.75K
|
|
SEC
|
MacAndrews & Forbes LLC
|
N/A
|
|
+204K
|
$1.34
|
+$273.57K
|
|
SEC
|
WEINER MICHAEL MD
|
N/A
|
|
-15K
|
$3.19
|
-$47.85K
|
|
SEC
|
BAYER MICHAEL J
|
N/A
|
|
+15K
|
$3.58
|
+$53.70K
|
|
SEC
|
BAYER MICHAEL J
|
N/A
|
|
-15K
|
$3.55
|
-$53.25K
|
|
SEC
|
SLOVIN BRUCE
|
N/A
|
|
-15K
|
$3.83
|
-$57.45K
|
|
SEC
|
Marshall Joseph W III
|
N/A
|
|
+7K
|
$3.59
|
+$25.13K
|
|
SEC
|
Bevins William C
|
N/A
|
|
+50K
|
$2.44
|
+$122.00K
|
|
SEC
|
Marshall Joseph W III
|
N/A
|
|
+5K
|
$3.02
|
+$15.10K
|
|
SEC
|
SAVAS PAUL G
|
N/A
|
|
+15K
|
$2.82
|
+$42.30K
|
|
SEC
|
SLOVIN BRUCE
|
N/A
|
|
+50K
|
$2.80
|
+$140.00K
|
|
SEC
|
STERN ANDREW L
|
N/A
|
|
+1.5K
|
$4.99
|
+$7.49K
|
|
SEC
|
Marshall Joseph W III
|
N/A
|
|
+3K
|
$5.45
|
+$16.35K
|
|
SEC
|
SAVAS PAUL G
|
N/A
|
|
+10K
|
$6.29
|
+$62.90K
|
|
SEC
|
TOWNSEND FRANCES F
|
N/A
|
|
+2K
|
$6.08
|
+$12.16K
|
|
SEC
|
SLOVIN BRUCE
|
N/A
|
|
+15K
|
$11.03
|
+$165.45K
|
|
SEC
|
CONSTANCE THOMAS E
|
N/A
|
|
-30K
|
$14.15
|
-$424.50K
|
|
SEC
|
WEINER MICHAEL MD
|
N/A
|
|
-10K
|
$14.15
|
-$141.50K
|
|
SEC
|
Hruby Dennis E
|
Chief Scientific Officer
|
|
-300K
|
$13.43
|
-$4.03M
|
|
SEC
|
Antal James
|
N/A
|
|
-25K
|
$13.64
|
-$341.00K
|
|
SEC
|
CONSTANCE THOMAS E
|
N/A
|
|
-26K
|
$14.03
|
-$368.53K
|
|
SEC
|
ROSE ERIC A MD
|
Chief Executive Officer
|
|
-42K
|
$13.65
|
-$566.48K
|
|
SEC
|
WEINER MICHAEL MD
|
N/A
|
|
-9K
|
$14.01
|
-$126.09K
|
|
SEC
|
Hruby Dennis E
|
Chief Scientific Officer
|
|
-125K
|
$6.65
|
-$831.25K
|
|
SEC
|
WEINER MICHAEL MD
|
N/A
|
|
-21K
|
$6.66
|
-$139.86K
|
|
SEC
|
Fasman Steven L
|
N/A
|
|
+1K
|
$5.97
|
+$5.97K
|
|
SEC
|
ROSE ERIC A MD
|
Chief Executive Officer
|
|
+7.1K
|
$6.00
|
+$42.60K
|
|
SEC
|
SAVAS PAUL G
|
N/A
|
|
+10K
|
$6.00
|
+$60.00K
|
|
SEC
|
WEINER MICHAEL MD
|
N/A
|
|
-20K
|
$9.01
|
-$180.20K
|
|
SEC
|
MJALLI ADNAN M M
|
N/A
|
|
-3.9M
|
$6.24
|
-$24.04M
|
|
SEC
|
STH Partners, L.P.
|
N/A
|
|
+3.9M
|
$6.24
|
+$24.04M
|
|
SEC
|
TRANSTECH PHARMA INC
|
N/A
|
|
-3.9M
|
$6.24
|
-$24.04M
|
|
SEC
|
SLOVIN BRUCE
|
N/A
|
|
+10K
|
$6.55
|
+$65.50K
|
|
SEC
|
WEINER MICHAEL MD
|
N/A
|
|
-30K
|
$7.69
|
-$230.70K
|
|
SEC
|
MacAndrews & Forbes LLC
|
N/A
|
|
+1M
|
$6.24
|
+$6.24M
|
|
SEC
|
MJALLI ADNAN M M
|
N/A
|
|
-1M
|
$6.24
|
-$6.24M
|
|
SEC
|
TRANSTECH PHARMA INC
|
N/A
|
|
-1M
|
$6.24
|
-$6.24M
|
|
SEC
|
SLOVIN BRUCE
|
N/A
|
|
+25K
|
$6.16
|
+$154.00K
|
|
SEC
|
WEINER MICHAEL MD
|
N/A
|
|
-20K
|
$6.10
|
-$122.00K
|
|
SEC
|
WEINER MICHAEL MD
|
N/A
|
|
-20K
|
$5.02
|
-$100.40K
|
|
SEC
|
SLOVIN BRUCE
|
N/A
|
|
+30K
|
$5.08
|
+$152.40K
|
|
SEC
|
ROSE ERIC A MD
|
Chief Executive Officer
|
|
+18K
|
$3.06
|
+$56.30K
|
|
SEC
|
SLOVIN BRUCE
|
N/A
|
|
+20K
|
$2.89
|
+$57.80K
|
|
SEC
|
SLOVIN BRUCE
|
N/A
|
|
+30K
|
$2.66
|
+$79.80K
|
|
SEC
|
WEINER MICHAEL MD
|
N/A
|
|
-13K
|
$3.38
|
-$42.25K
|
|
SEC
|
MacAndrews & Forbes Holdings Inc.
|
N/A
|
|
+288K
|
$3.63
|
+$1.05M
|
|
SEC
|
Odden John
|
VP - Business Development
|
|
+12K
|
$1.67
|
+$20.04K
|
|
SEC
|
Odden John
|
VP - Business Development
|
|
+13K
|
$1.55
|
+$20.77K
|
|
SEC
|
Odden John
|
VP - Business Development
|
|
+30K
|
$1.52
|
+$45.36K
|
|
SEC
|
KASTEN BERNARD L
|
Chief Executive Officer
|
|
+54K
|
$1.44
|
+$77.12K
|
|
SEC
|
BURGESS SUSAN K
|
N/A
|
|
-10K
|
$1.50
|
-$15.00K
|
|
SEC
|
BURGESS SUSAN K
|
President
|
|
-24K
|
$1.90
|
-$45.60K
|
|
SEC
|
BURGESS SUSAN K
|
President
|
|
-3K
|
$1.84
|
-$5.52K
|
|
SEC
|
BURGESS SUSAN K
|
President
|
|
-23K
|
$2.09
|
-$48.07K
|
|